XML 33 R20.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders’ Equity (Tables)
 9 Months Ended
Sep. 30, 2023
Stockholders’ Equity [Abstract]  
Schedule of Total Stock-Based Expenses Related to Stock Options During the nine months ended September 30, 2023, the Company recognized total stock-based expenses related to stock options of $914,426 which has been reflected in general and administrative expenses on the unaudited statements of operations and comprehensive loss. A balance of $142,835 remains to be expensed over future vesting periods related to unvested stock options issued for services to be expensed over a weighted average period of 2.44 years.
   Number of
Options		   Weighted
Average
Exercise
Price		   Weighted
Average
Remaining
Contractual
Life
(Years)		 
Balance on December 31, 2022   
   -
   $
   -
    
   -
 
Granted   460,000    4.15    
-
 
Balance on September 30, 2023   460,000   $4.15    8.74 
Options exercisable on September 30, 2023   350,000   $4.15    9.38 
Weighted average fair value of options granted during the period   
-
   $2.30    
-
 
Schedule of Warrant Activity Warrant activity for the nine months ended September 30, 2023 are summarized as follows:
   Number of Warrants   Weighted
Average
Exercise
Price		   Weighted
Average
Remaining
Contractual
Term
(Years)		   Aggregate
Intrinsic
Value		 
Balance Outstanding, December 31, 2022   
-
   $
-
    
-
    
             -
 
Granted   1,686,747    4.565    
-
    
-
 
Balance Outstanding, September 30, 2023   1,686,747   $4.565    4.38    
-
 
Exercisable, September 30, 2023   1,686,747   $4.565    4.38    
-